PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Min Luo, Yuhui Xia, Fang Wang, Hong Zhang, Danting Su, Chaoyue Su, Chuan Yang, Shaocong Wu, Sainan An, Suxia Lin, Liwu Fu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 10, 2021 Category: Cancer & Oncology Source Type: research
Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yuli Wang, Xingyan Zhang, Yuyan Wang, Wenjing Zhao, Huling Li, Lixing Zhang, Xinping Li, Tiejun Zhang, Hongbing Zhang, He Huang, Changxiao Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 10, 2021 Category: Cancer & Oncology Source Type: research
Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Qi Lv, Yao Xing, Jian Liu, Dong Dong, Yue Liu, Hongzhi Qiao, Yinan Zhang, Lihong Hu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 10, 2021 Category: Cancer & Oncology Source Type: research
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yongchao Wang, Jinjin Wang, Dandan Zhu, Yufei Wang, Guangchao Qing, Yuxuan Zhang, Xiaoxuan Liu, Xing-Jie Liang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 10, 2021 Category: Cancer & Oncology Source Type: research
Trends in the biological functions and medical applications of extracellular vesicles and analogues
Publication date: Available online 10 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yan Zhao, Xiaolu Li, Wenbo Zhang, Lanlan Yu, Yang Wang, Zhun Deng, Mingwei Liu, Shanshan Mo, Ruonan Wang, Jinming Zhao, Shuli Liu, Yun Hao, Xiangdong Wang, Tianjiao Ji, Luo Zhang, Chenxuan Wang (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 10, 2021 Category: Cancer & Oncology Source Type: research
Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, DeZhen Peng, Danyu Du, Xian Zhang, Luwei Han, Liwen Zhao, Ligong Lu, Hongzhi Du, Shengtao Yuan, Meixiao Zhan (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 9, 2021 Category: Cancer & Oncology Source Type: research
Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ziru Yu, Dewen Kong, Yu Liang, Xiaoyue Zhao, Guanhua Du (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 9, 2021 Category: Cancer & Oncology Source Type: research
Advances and challenges in the treatment of esophageal cancer
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Shiming He, Jian Xu, Xiujun Liu, Yongsu Zhen (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 9, 2021 Category: Cancer & Oncology Source Type: research
Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK-3β/IL-8 signaling pathway
Publication date: Available online 9 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Yumiao Zhao, Jiaxin Sun, Yin Li, Xiuman Zhou, Wenjie Zhai, Yahong Wu, Guanyu Chen, Shanshan Gou, Xinghua Sui, Wenshan Zhao, Lu Qiu, Yongjie Yao, Yixuan Sun, Chunxia Chen, Yuanming Qi, Yanfeng Gao (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 9, 2021 Category: Cancer & Oncology Source Type: research
Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands
Publication date: Available online 4 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Jianbo Sun, Hui Zhong, Kun Wang, Na Li, Li Chen (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 5, 2021 Category: Cancer & Oncology Source Type: research
The biological fate of the polymer nanocarrier material monomethoxy poly(ethylene glycol)-block-poly(D,L-lactic acid) in rat
Publication date: Available online 4 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Xiangjun Meng, Zhi Zhang, Jin Tong, Hui Sun, John Paul Fawcett, Jingkai Gu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 5, 2021 Category: Cancer & Oncology Source Type: research
The cellular immunotherapy of integrated photothermal anti-oxidation Pd-Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis
Publication date: Available online 4 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Chuping Zheng, Aiping Wu, Xinyun Zhai, Hong Ji, Zhikang Chen, Xu Chen, Xiyong Yu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 5, 2021 Category: Cancer & Oncology Source Type: research
In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions
Publication date: Available online 1 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ana L. Martínez-López, Carlos J. González-Navarro, Paula Aranaz, José L. Vizmanos, Juan M. Irache (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - March 3, 2021 Category: Cancer & Oncology Source Type: research
Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers
Publication date: Available online 27 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Samrat Mazumdar, Deepak Chitkara, Anupama Mittal (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 28, 2021 Category: Cancer & Oncology Source Type: research
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson’s disease
Publication date: Available online 26 February 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Kai Zhang, Shiou Zhu, Jiamei Li, Tingting Jiang, Lu Feng, Junping Pei, Guan Wang, Liang Ouyang, Bo Liu (Source: Acta Pharmaceutica Sinica B)
Source: Acta Pharmaceutica Sinica B - February 27, 2021 Category: Cancer & Oncology Source Type: research
